The Lancet Oncology · 2014 · 292 citations · 14 references
MedicineOncologyPharmacologyMetastasisNeoplasiaTumor ProgressionMalignant NeoplasmsMelanoma PharmacotherapyMetastatic Cancer ManagementMetastatic Disease ManagementMetastatic Disease TreatmentTargeted Cancer TherapyMek InhibitorsMelanoma ProgressionMetastatic Melanoma Treatment
14
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
American Association of Industrial Nurses Journal · 1968 · 8.9K citations
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text
Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text
Medicine, Oncology, Pharmacology +16